Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men.

[1]  R. Abbate,et al.  Circulating levels of Nɛ-(carboxymethyl)lysine are increased in systemic sclerosis , 2007 .

[2]  C. Visser,et al.  Nϵ-(Carboxymethyl)lysine Depositions in Intramyocardial Blood Vessels in Human and Rat Acute Myocardial Infarction: A Predictor or Reflection of Infarction? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[3]  M. Quon,et al.  Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms , 2006, Circulation.

[4]  C. Stehouwer,et al.  Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  Mikael Fogelholm,et al.  [Nordic nutrition recommendations]. , 2006, Ugeskrift for laeger.

[6]  Barbara Thorand,et al.  Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[7]  A. Hamsten,et al.  Measures of Oxidized Low-Density Lipoprotein and Oxidative Stress Are Not Related and Not Elevated in Otherwise Healthy Men With the Metabolic Syndrome , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[8]  R. D'Agostino,et al.  Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus , 2005, Circulation.

[9]  R. Krauss,et al.  Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. , 2005, Cardiology in review.

[10]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[11]  G. Hallmans,et al.  Trends in food intakes in Swedish adults 1986–1999: findings from the Northern Sweden MONICA (Monitoring of Trends and Determinants in Cardiovascular Disease) Study , 2005, Public Health Nutrition.

[12]  G. Rosito,et al.  Early and late effects of alcohol ingestion on blood pressure and endothelial function. , 2005, Alcohol.

[13]  Christopher J. Lyon,et al.  Insulin resistance and the endothelium , 2005, The American journal of medicine.

[14]  S. Rosenkranz,et al.  Alcohol consumption and hypertension , 2005, Current Hypertension Reports.

[15]  A. Fornoni,et al.  Metabolic syndrome and endothelial dysfunction , 2005, Current hypertension reports.

[16]  C. Stehouwer,et al.  Endothelial Dysfunction, Cellular Adhesion Molecules and the Metabolic Syndrome , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[17]  A. Singhal.  Endothelial dysfunction: role in obesity-related disorders and the early origins of CVD , 2005, The Proceedings of the Nutrition Society.

[18]  G. Johansson,et al.  The relation between alcohol intake and physical activity and the fatty acids 14: 0, 15: 0 and 17: 0 in serum phospholipids and adipose tissue used as markers for dairy fat intake , 2005, British Journal of Nutrition.

[19]  Ralph B D'Agostino,et al.  Trends in cardiovascular complications of diabetes. , 2004, JAMA.

[20]  M. Runge,et al.  Oxidative Stress and Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[21]  G. Johansson,et al.  Associations between the intake of dairy fat and calcium and abdominal obesity , 2004, International Journal of Obesity.

[22]  L. Monti,et al.  Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. , 2004, European journal of endocrinology.

[23]  R. de Caterina,et al.  Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. , 2004, Cardiovascular research.

[24]  J. Uribarri,et al.  High Levels of Dietary Advanced Glycation End Products Transform Low-Dersity Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients , 2004, Circulation.

[25]  A. Hamsten,et al.  Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men. , 2004, The Journal of nutrition.

[26]  J. Manson,et al.  Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. , 2004, The Journal of nutrition.

[27]  J. Uribarri,et al.  The role of advanced glycation end products in the development of atherosclerosis , 2004, Current diabetes reports.

[28]  A. Blann.  Assessment of Endothelial Dysfunction: Focus on Atherothrombotic Disease , 2003, Pathophysiology of Haemostasis and Thrombosis.

[29]  C. Mineo,et al.  HDL stimulation of endothelial nitric oxide synthase: a novel mechanism of HDL action. , 2003, Trends in cardiovascular medicine.

[30]  R. Karas,et al.  Clinical Utility of Endothelial Function Testing: Ready for Prime Time? , 2003, Circulation.

[31]  G. Johansson,et al.  Associations between diet and the metabolic syndrome vary with the validity of dietary intake data. , 2003, The American journal of clinical nutrition.

[32]  A. Donker,et al.  Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  M. Peppa,et al.  Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Fagerberg,et al.  Circulating oxidized low‐density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58‐year‐old men (AIR study) , 2002, Journal of internal medicine.

[35]  R. Bucala,et al.  Advanced glycation end products and endothelial dysfunction in type 2 diabetes. , 2002, Diabetes care.

[36]  R. de Caterina,et al.  Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses , 2002, Circulation.

[37]  T. Miyata,et al.  Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells. , 2001, Free radical biology & medicine.

[38]  S. Grundy,et al.  Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy. , 2001, Metabolism: clinical and experimental.

[39]  James T. Willerson,et al.  Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells , 2000, Circulation.

[40]  A. Carr,et al.  Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. , 1999, The American journal of clinical nutrition.

[41]  D. Morel,et al.  Dietary supplementation with β-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low-density lipoprotein , 1999 .

[42]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[43]  F. Bartolomucci,et al.  Noninvasive detection of vascular dysfunction in alcoholic patients. , 1999, American journal of hypertension.

[44]  T. Luther,et al.  Advanced Glycation End Product-Induced Activation of NF-κB is Suppressed by α-Lipoic Acid in Cultured Endothelial Cells , 1997, Diabetes.

[45]  C. Schalkwijk,et al.  [Vascular complications in diabetes mellitus: role of endothelial dysfunction]. , 1996, Nederlands tijdschrift voor geneeskunde.

[46]  M. Cybulsky,et al.  Advanced Glycation Endproducts Promote Adhesion Molecule (VCAM-1, ICAM-1) Expression and Atheroma Formation in Normal Rabbits , 1995, Molecular medicine.

[47]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[48]  T. Yamamoto,et al.  Application of an enzyme-linked immunosorbent assay (ELISA) to von Willebrand factor (vWF) and its derivatives. , 1986, Thrombosis research.

[49]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[50]  B. Vessby,et al.  Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. , 1985, Clinical science.

[51]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[52]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[53]  A. Blann,et al.  Soluble markers of endothelial cell function. , 1997, Clinical hemorheology and microcirculation.

[54]  A. Aljada,et al.  Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation , 2022 .